Andorsky et al., Am. J. Gastroent. 85:261(1990). |
Attar et al., Gutt 44:226 (1999). |
Hammer et al., J Clin. Invest. 84:1056-62(1989). |
Hudziak et al., Gastroenterol Clin. Biol. 20:418-23. |
Stoltz, R., et al., “An Efficacy and Consumer Preference Study of MiraLax (Polyethylene Glycol 3350) for the Treatment of Constipation in Regular Laxative Users”, Home Healthcare Consultant 2001, 8(2) :pp. 21-25. |
Chaussade, S. and Minic, M., Comparison of efficacy and safety of two doses of two different polyethylene glycol-based laxatives in the treatment of constipation. Aliment Pharmacol Ther. Jan. 2003; 17 (1) :165-72,pp. 165-175. |
Culbert, et al., “Highly Effective Oral Therapy (Polyethyleneglycol/electrolyte solution) for Faecal Impaction and Sever Constipation”, Clin Drug Invest.1998, 16 (5) :pp. 355-360. |
Di Palma, J.A., et al., “Overnight efficacy of polyethylene glycol laxative”, American Journal of Gastroenterology 2002, 97(7) :pp. 1776-1779. |